title: Urothelial carcinoma in kidney transplant recipients: conversion from calcineurin inhibitor to proliferation signal inhibitor?
authors: Shiu-Dong
authors: SD
authors: Chung
authors: Ming-Kuen
authors: MK
authors: Lai
authors: Shuo-Meng
authors: SM
authors: Wang
authors: Chun-Hou
authors: CH
authors: Liao
authors: Hong-Jeng
authors: HJ
authors: Yu
authors: Shih-Chieh
authors: SC
authors: Chueh
mesh_terms: D065095:Calcineurin Inhibitors; D049109:Cell Proliferation; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D011182:Postoperative Care; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000209:etiology* / Q000517:prevention & control
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus